Abstract

Objective: This study was undertaken to investigate the effects of the polyamine spermine on human uterine contractility. Study design: Under physiologic conditions, an isometric tension recording was performed in isolated myometrial strips from biopsy specimens obtained at elective cesarean delivery (n = 24 specimens) and from premenopausal hysterectomy specimens (n = 6 specimens). The effects of spermine (1 μmol/L-10 mmol/L in cumulative doses) on spontaneous, agonist-induced myometrial contractions were measured, and dose response curves were constructed. The pD2 (−log EC50) values and the maximal inhibition values achieved were compared for spontaneous and agonist-induced contractions. Results: Spermine exerted a potent relaxant effect on all spontaneous and agonist-induced myometrial contractions, with mean maximal inhibition values between 62.8% ± 4.3% and 91.4% ± 1.8% and pD2 values between 2.66 ± 0.23 and 4.01 ± 0.20. Its inhibitory effect varied significantly with different contraction types (pD2, P < .05; mean maximal inhibition, P < .001), and it was least potent on BAY K 8644-elicited contractions (pD2, P < .05; mean maximal inhibition, P < .01). Conclusion: The polyamine spermine exerts a potent relaxant effect on human uterine tissue. This effect appears to be mediated, at least partially, by calcium antagonism. Polyamines may play a role in the maintenance of uterine quiescence during pregnancy. (Am J Obstet Gynecol 2002;186:778-83.)

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.